A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we...
Gespeichert in:
Veröffentlicht in: | Virchows Archiv : an international journal of pathology 2020-12, Vol.477 (6), p.865-872 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 872 |
---|---|
container_issue | 6 |
container_start_page | 865 |
container_title | Virchows Archiv : an international journal of pathology |
container_volume | 477 |
creator | Bjerkli, Inger-Heidi Hadler-Olsen, Elin Nginamau, Elisabeth Sivy Laurvik, Helene Søland, Tine M. Costea, Daniela Elena Uhlin-Hansen, Lars Steigen, Sonja E. |
description | We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value. |
doi_str_mv | 10.1007/s00428-020-02875-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7683438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2473380264</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-f7dcd82328254364ccb5bea7fbba601ccfc6a11ed698a05f5d7504016125bc583</originalsourceid><addsrcrecordid>eNp9UsuOFCEUJUbjtKM_4EJJ3Lgp5Q21MZlMfCWTuNE1AQq6GaugBcqkv8DflrZnxsfCBSG599xzzn0A8BSjVxgh-boixIgaEEH9KcmH8R7YYEbJQCiS98EGjYwPgmJ5Bh7Veo0QwQqLh-CMEoGkUHIDflxAlxcbk5_gLtaWh-py8dCa2iM5wbYuucAphuCLTy2aFnvUpAnOh2W_y-7QooMxhTi3YpqHsUIDS7ZrbXBf8jblekQspnz1BYZOtmQbZw9bTtvVQ2eS8-UxeBDMXP2Tm_8cfHn39vPlh-Hq0_uPlxdXg2OjakOQk5sUoUQRzqhgzlluvZHBWiMQdi44YTD2kxiVQTzwSXLEEBaYcOu4oufgzYl3v9rFT663VMys9yV2gwedTdR_Z1Lc6W3-rvu4KKNHgucnAlf6uGLSKRej-z6o1FiNmHbEyxuJkr-tvja9xOr8PJvk81o1YXhk3T46kr34B3qd15L6ADpKUqoQEayjyK1krrX4cGcXo6Oy1KdL0P0S9K9L0GMvevZno3clt6vvAHoC1J5KW19-a_-H9ieHrcDT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473380264</pqid></control><display><type>article</type><title>A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer</title><source>MEDLINE</source><source>NORA - Norwegian Open Research Archives</source><source>Springer Nature - Complete Springer Journals</source><creator>Bjerkli, Inger-Heidi ; Hadler-Olsen, Elin ; Nginamau, Elisabeth Sivy ; Laurvik, Helene ; Søland, Tine M. ; Costea, Daniela Elena ; Uhlin-Hansen, Lars ; Steigen, Sonja E.</creator><creatorcontrib>Bjerkli, Inger-Heidi ; Hadler-Olsen, Elin ; Nginamau, Elisabeth Sivy ; Laurvik, Helene ; Søland, Tine M. ; Costea, Daniela Elena ; Uhlin-Hansen, Lars ; Steigen, Sonja E.</creatorcontrib><description>We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value.</description><identifier>ISSN: 0945-6317</identifier><identifier>ISSN: 1432-2307</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-020-02875-9</identifier><identifier>PMID: 32607687</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Basale medisinske, odontologiske og veterinærmedisinske fag: 710 ; Basic medical, dental and veterinary science disciplines: 710 ; Cancer ; Cell Differentiation ; Differentiation ; Female ; Health services ; Humans ; Infiltration ; Lymph nodes ; Lymphocytes, Tumor-Infiltrating - immunology ; Lymphocytes, Tumor-Infiltrating - pathology ; Male ; Medical disciplines: 700 ; Medical prognosis ; Medicine ; Medicine & Public Health ; Medisinske Fag: 700 ; Metastases ; Middle Aged ; Oral cancer ; Oral carcinoma ; Original ; Original Article ; Pathology ; Patients ; Prognosis ; Scoring models ; Squamous cell carcinoma ; Squamous Cell Carcinoma of Head and Neck - immunology ; Squamous Cell Carcinoma of Head and Neck - mortality ; Squamous Cell Carcinoma of Head and Neck - pathology ; Survival ; Tongue ; Tongue Neoplasms - immunology ; Tongue Neoplasms - mortality ; Tongue Neoplasms - pathology ; Tumors ; VDP</subject><ispartof>Virchows Archiv : an international journal of pathology, 2020-12, Vol.477 (6), p.865-872</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>info:eu-repo/semantics/openAccess</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-f7dcd82328254364ccb5bea7fbba601ccfc6a11ed698a05f5d7504016125bc583</citedby><cites>FETCH-LOGICAL-c498t-f7dcd82328254364ccb5bea7fbba601ccfc6a11ed698a05f5d7504016125bc583</cites><orcidid>0000-0001-8376-2489</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00428-020-02875-9$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00428-020-02875-9$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,26544,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32607687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bjerkli, Inger-Heidi</creatorcontrib><creatorcontrib>Hadler-Olsen, Elin</creatorcontrib><creatorcontrib>Nginamau, Elisabeth Sivy</creatorcontrib><creatorcontrib>Laurvik, Helene</creatorcontrib><creatorcontrib>Søland, Tine M.</creatorcontrib><creatorcontrib>Costea, Daniela Elena</creatorcontrib><creatorcontrib>Uhlin-Hansen, Lars</creatorcontrib><creatorcontrib>Steigen, Sonja E.</creatorcontrib><title>A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><addtitle>Virchows Arch</addtitle><description>We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Basale medisinske, odontologiske og veterinærmedisinske fag: 710</subject><subject>Basic medical, dental and veterinary science disciplines: 710</subject><subject>Cancer</subject><subject>Cell Differentiation</subject><subject>Differentiation</subject><subject>Female</subject><subject>Health services</subject><subject>Humans</subject><subject>Infiltration</subject><subject>Lymph nodes</subject><subject>Lymphocytes, Tumor-Infiltrating - immunology</subject><subject>Lymphocytes, Tumor-Infiltrating - pathology</subject><subject>Male</subject><subject>Medical disciplines: 700</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Medisinske Fag: 700</subject><subject>Metastases</subject><subject>Middle Aged</subject><subject>Oral cancer</subject><subject>Oral carcinoma</subject><subject>Original</subject><subject>Original Article</subject><subject>Pathology</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Scoring models</subject><subject>Squamous cell carcinoma</subject><subject>Squamous Cell Carcinoma of Head and Neck - immunology</subject><subject>Squamous Cell Carcinoma of Head and Neck - mortality</subject><subject>Squamous Cell Carcinoma of Head and Neck - pathology</subject><subject>Survival</subject><subject>Tongue</subject><subject>Tongue Neoplasms - immunology</subject><subject>Tongue Neoplasms - mortality</subject><subject>Tongue Neoplasms - pathology</subject><subject>Tumors</subject><subject>VDP</subject><issn>0945-6317</issn><issn>1432-2307</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>3HK</sourceid><recordid>eNp9UsuOFCEUJUbjtKM_4EJJ3Lgp5Q21MZlMfCWTuNE1AQq6GaugBcqkv8DflrZnxsfCBSG599xzzn0A8BSjVxgh-boixIgaEEH9KcmH8R7YYEbJQCiS98EGjYwPgmJ5Bh7Veo0QwQqLh-CMEoGkUHIDflxAlxcbk5_gLtaWh-py8dCa2iM5wbYuucAphuCLTy2aFnvUpAnOh2W_y-7QooMxhTi3YpqHsUIDS7ZrbXBf8jblekQspnz1BYZOtmQbZw9bTtvVQ2eS8-UxeBDMXP2Tm_8cfHn39vPlh-Hq0_uPlxdXg2OjakOQk5sUoUQRzqhgzlluvZHBWiMQdi44YTD2kxiVQTzwSXLEEBaYcOu4oufgzYl3v9rFT663VMys9yV2gwedTdR_Z1Lc6W3-rvu4KKNHgucnAlf6uGLSKRej-z6o1FiNmHbEyxuJkr-tvja9xOr8PJvk81o1YXhk3T46kr34B3qd15L6ADpKUqoQEayjyK1krrX4cGcXo6Oy1KdL0P0S9K9L0GMvevZno3clt6vvAHoC1J5KW19-a_-H9ieHrcDT</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Bjerkli, Inger-Heidi</creator><creator>Hadler-Olsen, Elin</creator><creator>Nginamau, Elisabeth Sivy</creator><creator>Laurvik, Helene</creator><creator>Søland, Tine M.</creator><creator>Costea, Daniela Elena</creator><creator>Uhlin-Hansen, Lars</creator><creator>Steigen, Sonja E.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>Springer Nature</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>3HK</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8376-2489</orcidid></search><sort><creationdate>20201201</creationdate><title>A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer</title><author>Bjerkli, Inger-Heidi ; Hadler-Olsen, Elin ; Nginamau, Elisabeth Sivy ; Laurvik, Helene ; Søland, Tine M. ; Costea, Daniela Elena ; Uhlin-Hansen, Lars ; Steigen, Sonja E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-f7dcd82328254364ccb5bea7fbba601ccfc6a11ed698a05f5d7504016125bc583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Basale medisinske, odontologiske og veterinærmedisinske fag: 710</topic><topic>Basic medical, dental and veterinary science disciplines: 710</topic><topic>Cancer</topic><topic>Cell Differentiation</topic><topic>Differentiation</topic><topic>Female</topic><topic>Health services</topic><topic>Humans</topic><topic>Infiltration</topic><topic>Lymph nodes</topic><topic>Lymphocytes, Tumor-Infiltrating - immunology</topic><topic>Lymphocytes, Tumor-Infiltrating - pathology</topic><topic>Male</topic><topic>Medical disciplines: 700</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Medisinske Fag: 700</topic><topic>Metastases</topic><topic>Middle Aged</topic><topic>Oral cancer</topic><topic>Oral carcinoma</topic><topic>Original</topic><topic>Original Article</topic><topic>Pathology</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Scoring models</topic><topic>Squamous cell carcinoma</topic><topic>Squamous Cell Carcinoma of Head and Neck - immunology</topic><topic>Squamous Cell Carcinoma of Head and Neck - mortality</topic><topic>Squamous Cell Carcinoma of Head and Neck - pathology</topic><topic>Survival</topic><topic>Tongue</topic><topic>Tongue Neoplasms - immunology</topic><topic>Tongue Neoplasms - mortality</topic><topic>Tongue Neoplasms - pathology</topic><topic>Tumors</topic><topic>VDP</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bjerkli, Inger-Heidi</creatorcontrib><creatorcontrib>Hadler-Olsen, Elin</creatorcontrib><creatorcontrib>Nginamau, Elisabeth Sivy</creatorcontrib><creatorcontrib>Laurvik, Helene</creatorcontrib><creatorcontrib>Søland, Tine M.</creatorcontrib><creatorcontrib>Costea, Daniela Elena</creatorcontrib><creatorcontrib>Uhlin-Hansen, Lars</creatorcontrib><creatorcontrib>Steigen, Sonja E.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>NORA - Norwegian Open Research Archives</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bjerkli, Inger-Heidi</au><au>Hadler-Olsen, Elin</au><au>Nginamau, Elisabeth Sivy</au><au>Laurvik, Helene</au><au>Søland, Tine M.</au><au>Costea, Daniela Elena</au><au>Uhlin-Hansen, Lars</au><au>Steigen, Sonja E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><stitle>Virchows Arch</stitle><addtitle>Virchows Arch</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>477</volume><issue>6</issue><spage>865</spage><epage>872</epage><pages>865-872</pages><issn>0945-6317</issn><issn>1432-2307</issn><eissn>1432-2307</eissn><abstract>We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32607687</pmid><doi>10.1007/s00428-020-02875-9</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-8376-2489</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0945-6317 |
ispartof | Virchows Archiv : an international journal of pathology, 2020-12, Vol.477 (6), p.865-872 |
issn | 0945-6317 1432-2307 1432-2307 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7683438 |
source | MEDLINE; NORA - Norwegian Open Research Archives; Springer Nature - Complete Springer Journals |
subjects | Adult Aged Aged, 80 and over Basale medisinske, odontologiske og veterinærmedisinske fag: 710 Basic medical, dental and veterinary science disciplines: 710 Cancer Cell Differentiation Differentiation Female Health services Humans Infiltration Lymph nodes Lymphocytes, Tumor-Infiltrating - immunology Lymphocytes, Tumor-Infiltrating - pathology Male Medical disciplines: 700 Medical prognosis Medicine Medicine & Public Health Medisinske Fag: 700 Metastases Middle Aged Oral cancer Oral carcinoma Original Original Article Pathology Patients Prognosis Scoring models Squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck - immunology Squamous Cell Carcinoma of Head and Neck - mortality Squamous Cell Carcinoma of Head and Neck - pathology Survival Tongue Tongue Neoplasms - immunology Tongue Neoplasms - mortality Tongue Neoplasms - pathology Tumors VDP |
title | A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A55%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20combined%20histo-score%20based%20on%20tumor%20differentiation%20and%20lymphocytic%20infiltrate%20is%20a%20robust%20prognostic%20marker%20for%20mobile%20tongue%20cancer&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=Bjerkli,%20Inger-Heidi&rft.date=2020-12-01&rft.volume=477&rft.issue=6&rft.spage=865&rft.epage=872&rft.pages=865-872&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-020-02875-9&rft_dat=%3Cproquest_pubme%3E2473380264%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473380264&rft_id=info:pmid/32607687&rfr_iscdi=true |